Elena Losina, PhD is the codirector of the Orthopedics and Arthritis Center for Outcomes Research at Brigham and Women’s Hospital
Practical Applications of Cost-Effective Knee Osteoarthritis and Obesity Treatments: Elena Losina, PhD
Tirzepatide appears more cost-effective than semaglutide for obesity and knee osteoarthritis, though long-term data and patient-centered outcomes remain key.
Cost-Effectiveness and Policy Implications of Knee Osteoarthritis, Obesity Treatment: Elena Losina, PhD
Tirzepatide’s cost-effectiveness provides key evidence for policy makers implementing clinical coverage decisions.
Cost-Effectiveness of Varying Weight Loss Interventions: Elena Losina, PhD
Elena Losina, PhD, codirector of the Orthopedics and Arthritis Center for Outcomes Research at Brigham and Women’s Hospital, discusses the cost-effectiveness of varying weight loss interventions.